この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
規制と法律 · 1995/9/201 分で読めます
Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Hydrochloride Injection
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Phoenix Pharmaceutical, Inc. The ANADA provides for intravenous use of oxytetracycline hydrochloride injection in cattle for treatment of certain diseases caused by pathogens sensitive to oxytetracycline. EFFECTIVE DATE: September 20, 1995. FOR FURTHER INFORMATION CONTACT: Melanie R. Berson, Center For Veterinary Medicine (HFV-135), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-594-1643.
情報源の原言語: Federal Register — All Documents原文の発表を開く →